Researchers are also testing a number of other solutions that may help relieve the symptoms of interstitial cystitis, including hyaluronan, chondroitin sulfate and oxybutynin.
The first application, currently in clinical development, is to treat interstitial cystitis (IC), a painful bladder disease in women that forces them to urinate every 10 minutes.
It plans one for the stent product that it hopes will be approved in 2014 and another for the interstitial cystitis product expected to be approved in 2015.